Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-05

FDA Approved: VASOPRESSIN — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals LLC's original application for a generic vasopressin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASOPRESSIN (VASOPRESSIN)

Snippet

ORIG AP for VASOPRESSIN (VASOPRESSIN)